Pharmacovigilance Services
PPD’s pharmacovigilance (PVG) team is center stage in the global effort to improve safety management. In addition to helping meet the escalating demand for safety services, PPD is working to advance pharmacovigilance technologies and processes to improve efficiency and reduce cost. Most importantly, we are helping drug development and medical device clients identify and apply valuable insights based on pharmacovigilance data.
Global Capabilities: Quality Powered by Experience
At PPD, our teams deliver the highest levels of quality and compliance using innovative tools that reduce time and cost. Our global capabilities and technical expertise span the full range of pharmacovigilance practice, from clinical product development to late stage research and marketing. Executed by highly trained PVG experts and backed by years of experience, our pre- and post-approval services are based upon extensive knowledge and an uncompromising commitment to safety practice
PVG Services Span the Product Life Cycle
| Service Offering | Pre-approval | Post-approval |
| SAE and AE Management | * | * |
| Endpoint Coordination | * | |
| Safety Database Hosting | * | * |
| Strategic Medical Consulting | * | * |
| Regulatory and Third Party Submissions | * | * |
| Global Literature Surveillance | * | |
| Aggregate Reports (DSUR, PSUR, PADER) | * | * |
| DMC and CEC Management | * | |
| Signaling | * | * |
For more information about our pharmacovigilance services by phase of drug development, visit our Phase II-IIIb safety and pharmacovigilance page or our post-approval product safety and pharmacovigilance page.
